In human acute myeloid leukemia, activation of RANKL expressed by tumor cells leads to a dual inhibition of NK cells, through the secretion of immunomodulatory factors directly inhibiting NK cells and the upregulation of RANK expression by NK cells. The gene discussed is TNFRSF11A; the disease is acute myeloid leukemia.